Loss of SEL1L in myocytes leads to reprogramming of systemic metabolism, including enhanced adipocyte beigeing, increased insulin sensitivity, and resistance to diet-induced obesity, partly through the action of myocyte-derived FGF21. This evidence concerns the gene INS and obesity disorder.